Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Machado

Showing results (791-800 of 837) with videos related to

Pageof 84
Sort By:
Cellular Immunology|October 6, 2018
Diagnostic application of recombinant Leishmania proteins and evaluation of their in vitro immunogenicity after stimulation of immune cells collected from tegumentary leishmaniasis patients and healthy individualsMariana P Lima, Lourena E Costa, Daniela P Lage, et al.
Acta Tropica|July 4, 2025
Metabolic disruptions in P. vivax malaria: Insights from four antimalarial treatment regimensMichael N Yakubu, Victor I Mwangi, Anne C G Almeida, et al.
Inflammopharmacology|September 4, 2023
Anti-inflammatory and antinociceptive effects, and safety toxicological profile of a new paracetamol analog, LQFM291Larissa Córdova Turones, Lucas S Machado, Boniek G Vaz, et al.
International Journal of Molecular Sciences|July 15, 2026
Prenylated p-Coumaric Acid Derivatives Mitigate Neurobehavioral and Neuroinflammatory Alterations Associated with Experimental ColitisCamila A Cazarin, Bruna Longo, Eduarda R Bauer, et al.
Acta Tropica|March 20, 2022
A recombinant Leishmania amastigote-specific protein, rLiHyG, with adjuvants, protects against infection with Leishmania infantumAmanda S Machado, Daniela P Lage, Danniele L Vale, et al.
Parasite Immunology|April 19, 2022
Leishmania LiHyC protein is immunogenic and induces protection against visceral leishmaniasisAmanda S Machado, Daniela P Lage, Danniele L Vale, et al.
Msystems|October 24, 2023
Methylprednisolone therapy induces differential metabolic trajectories in severe COVID-19 patientsVictor I Mwangi, Rebeca L A Netto, Mayla G S Borba, et al.
EJNMMI Research|April 1, 2025
Autoradiographic comparison between [<sup>11</sup>C]PiB and [<sup>18</sup>F]AZD4694 in human brain tissueAntonio Aliaga, Joseph Therriault, Kely Quispialaya, et al.
Vaccines|June 13, 2020
Liposomal Formulation of ChimeraT, a Multiple T-Cell Epitope-Containing Recombinant Protein, Is a Candidate Vaccine for Human Visceral LeishmaniasisDaniela P Lage, Patrícia A F Ribeiro, Daniel S Dias, et al.
Experimental Parasitology|December 18, 2020
Ivermectin presents effective and selective antileishmanial activity in vitro and in vivo against Leishmania infantum and is therapeutic against visceral leishmaniasisThiago A R Reis, João A Oliveira-da-Silva, Grasiele S V Tavares, et al.
Pageof 84

Showing results (791-800 of 837) with videos related to

Sort By:
Pageof 84
Cellular Immunology|October 6, 2018
Diagnostic application of recombinant Leishmania proteins and evaluation of their in vitro immunogenicity after stimulation of immune cells collected from tegumentary leishmaniasis patients and healthy individualsMariana P Lima, Lourena E Costa, Daniela P Lage, et al.
Acta Tropica|July 4, 2025
Metabolic disruptions in P. vivax malaria: Insights from four antimalarial treatment regimensMichael N Yakubu, Victor I Mwangi, Anne C G Almeida, et al.
Inflammopharmacology|September 4, 2023
Anti-inflammatory and antinociceptive effects, and safety toxicological profile of a new paracetamol analog, LQFM291Larissa Córdova Turones, Lucas S Machado, Boniek G Vaz, et al.
International Journal of Molecular Sciences|July 15, 2026
Prenylated p-Coumaric Acid Derivatives Mitigate Neurobehavioral and Neuroinflammatory Alterations Associated with Experimental ColitisCamila A Cazarin, Bruna Longo, Eduarda R Bauer, et al.
Acta Tropica|March 20, 2022
A recombinant Leishmania amastigote-specific protein, rLiHyG, with adjuvants, protects against infection with Leishmania infantumAmanda S Machado, Daniela P Lage, Danniele L Vale, et al.
Parasite Immunology|April 19, 2022
Leishmania LiHyC protein is immunogenic and induces protection against visceral leishmaniasisAmanda S Machado, Daniela P Lage, Danniele L Vale, et al.
Msystems|October 24, 2023
Methylprednisolone therapy induces differential metabolic trajectories in severe COVID-19 patientsVictor I Mwangi, Rebeca L A Netto, Mayla G S Borba, et al.
EJNMMI Research|April 1, 2025
Autoradiographic comparison between [<sup>11</sup>C]PiB and [<sup>18</sup>F]AZD4694 in human brain tissueAntonio Aliaga, Joseph Therriault, Kely Quispialaya, et al.
Vaccines|June 13, 2020
Liposomal Formulation of ChimeraT, a Multiple T-Cell Epitope-Containing Recombinant Protein, Is a Candidate Vaccine for Human Visceral LeishmaniasisDaniela P Lage, Patrícia A F Ribeiro, Daniel S Dias, et al.
Experimental Parasitology|December 18, 2020
Ivermectin presents effective and selective antileishmanial activity in vitro and in vivo against Leishmania infantum and is therapeutic against visceral leishmaniasisThiago A R Reis, João A Oliveira-da-Silva, Grasiele S V Tavares, et al.
Pageof 84